Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).
Lewis LD, Miller AA, Owzar K, Bies RR, Markova S, Jiang C, Kroetz DL, Egorin MJ, McLeod HL, Ratain MJ; Alliance for Clinical Trials in Oncology.
Pharmacogenet Genomics. 2013 Jan;23(1):29-33. doi: 10.1097/FPC.0b013e32835b16d8.
Related citations
The vesicular transport assay: validated in vitro methods to study drug-mediated inhibition of canalicular efflux transporters ABCB11/BSEP and ABCC2/MRP2.
Herédi-Szabó K, Kis E, Krajcsi P.
Curr Protoc Toxicol. 2012 Nov;Chapter 23:Unit 23.4. doi: 10.1002/0471140856.tx2304s54.
UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients.
Fukuda T, Goebel J, Cox S, Maseck D, Zhang K, Sherbotie JR, Ellis EN, James LP, Ward RM, Vinks AA.
Ther Drug Monit. 2012 Dec;34(6):671-9. doi: 10.1097/FTD.0b013e3182708f84.
Novel mutations in the Dubin-Johnson syndrome gene ABCC2/MRP2 and associated biochemical changes.
Devgun MS, El-Nujumi AM, O'Dowd GJ, Barbu V, Poupon R.
Ann Clin Biochem. 2012 Nov;49(Pt 6):609-12. doi: 10.1258/acb.2012.011279. Epub 2012 Oct 12.
Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo.
Hill CR, Jamieson D, Thomas HD, Brown CD, Boddy AV, Veal GJ.
Biochem Pharmacol. 2013 Jan 1;85(1):29-37. doi: 10.1016/j.bcp.2012.10.004. Epub 2012 Oct 11.
ABCC2 is involved in the hepatocyte perinuclear barrier for small organic compounds.
Rosales R, Monte MJ, Blazquez AG, Briz O, Marin JJ.
Biochem Pharmacol. 2012 Dec 15;84(12):1651-9. doi: 10.1016/j.bcp.2012.09.029. Epub 2012 Oct 3.
Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.
Nishijima T, Komatsu H, Higasa K, Takano M, Tsuchiya K, Hayashida T, Oka S, Gatanaga H.
Clin Infect Dis. 2012 Dec;55(11):1558-67. doi: 10.1093/cid/cis772. Epub 2012 Sep 5.
Protein kinase Cδ differentially regulates cAMP-dependent translocation of NTCP and MRP2 to the plasma membrane.
Park SW, Schonhoff CM, Webster CR, Anwer MS.
Am J Physiol Gastrointest Liver Physiol. 2012 Sep 1;303(5):G657-65. doi: 10.1152/ajpgi.00529.2011. Epub 2012 Jun 28.
Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.
Endo S, Fukahori A, Tokuhiro S, Shinagawa A, Walker J, Yoshihara K, Ishizuka H, Ieiri I, Sugiyama Y.
J Hum Genet. 2012 Aug;57(8):531-44. doi: 10.1038/jhg.2012.63. Epub 2012 Jun 14.
Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse.
Foster JR, Jacobsen M, Kenna G, Schulz-Utermoehl T, Morikawa Y, Salmu J, Wilson ID.
Toxicol Pathol. 2012 Dec;40(8):1106-16. doi: 10.1177/0192623312447542. Epub 2012 Jun 6.
ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH, Tang Q, Zhou HH, Liu ZQ.
CNS Neurosci Ther. 2012 Aug;18(8):647-51. doi: 10.1111/j.1755-5949.2012.00336.x. Epub 2012 May 28.
Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
Grover S, Gourie-Devi M, Bala K, Sharma S, Kukreti R.
Pharmacogenet Genomics. 2012 Jun;22(6):447-65. doi: 10.1097/FPC.0b013e3283528217.
Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy.
Sprowl JA, Gregorc V, Lazzari C, Mathijssen RH, Loos WJ, Sparreboom A.
Clin Pharmacol Ther. 2012 Jun;91(6):1022-6. doi: 10.1038/clpt.2011.330.
Influence of ABCC2, SLCO1B1, and ABCG2 polymorphisms on the pharmacokinetics of olmesartan.
Kim CO, Cho SK, Oh ES, Park MS, Chung JY.
J Cardiovasc Pharmacol. 2012 Jul;60(1):49-54. doi: 10.1097/FJC.0b013e3182576098.
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis.
Campa D, Müller P, Edler L, Knoefel L, Barale R, Heussel CP, Thomas M, Canzian F, Risch A.
Int J Cancer. 2012 Dec 15;131(12):2920-8. doi: 10.1002/ijc.27567. Epub 2012 Jul 3.
The effect of radixin knockdown on the expression and efflux function of MRP2 in SGC-7901 cells.
He XJ, Wang WR, Zhang Y, Yang Q.
Eur J Pharm Sci. 2012 Aug 15;46(5):426-34. doi: 10.1016/j.ejps.2012.03.006. Epub 2012 Mar 25.
A cis-acting five-amino-acid motif controls targeting of ABCC2 to the apical plasma membrane domain.
Emi Y, Yasuda Y, Sakaguchi M.
J Cell Sci. 2012 Jul 1;125(Pt 13):3133-43. doi: 10.1242/jcs.099549. Epub 2012 Mar 27.
ABCC2 transporter gene polymorphisms, diet and risk of colorectal cancer: a Danish prospective cohort study.
Andersen V, Egeberg R, Tjønneland A, Vogel U.
Scand J Gastroenterol. 2012 May;47(5):572-4. doi: 10.3109/00365521.2012.668933. Epub 2012 Mar 20. No abstract available.
Impact of probe compound in MRP2 vesicular transport assays.
Kidron H, Wissel G, Manevski N, Häkli M, Ketola RA, Finel M, Yliperttula M, Xhaard H, Urtti A.
Eur J Pharm Sci. 2012 May 12;46(1-2):100-5. doi: 10.1016/j.ejps.2012.02.016. Epub 2012 Mar 3.
Rat Mrp2 gene expression is regulated by an interleukin-1β-stimulated biphasic response with enhanced transcription and subcellular shuttling of YB-1.
Mertens PR, Martin IV, Frye BC, Rauen T, Strauch S, Pabst M, Geier A.
Eur J Cell Biol. 2012 Jun-Jul;91(6-7):533-41. doi: 10.1016/j.ejcb.2011.12.002. Epub 2012 Feb 22.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on